Clinic Pro UK
Health

What Does a Low TSH Mean? Overactive Thyroid Explained in Plain English

A low TSH is one of the most confusing blood test results to receive because the relationship between the hormones works in reverse. This guide explains what a suppressed or low TSH actually means, what causes it, and what happens next.

Dom PaulDom Paul·4 July 2026·9 min read

A low TSH does not mean your thyroid is underperforming. It means the opposite. This is the detail that confuses most people who receive a thyroid result, and it is worth understanding before anything else.

TSH is produced by the pituitary gland, not the thyroid. When thyroid hormone levels in the blood are too high, the pituitary responds by producing less TSH. A low TSH is the pituitary's way of signalling that the thyroid is already working too hard. It is a suppressed brake, not a failing engine.

  1. How the thyroid hormone system works
  2. What is a normal TSH level in the UK
  3. What a low or suppressed TSH means
  4. Symptoms of an overactive thyroid
  5. What causes a low TSH
  6. Subclinical hyperthyroidism: low TSH with normal T4 and T3
  7. How an overactive thyroid is diagnosed
  8. Treatment options for hyperthyroidism in the UK
  9. A low TSH on levothyroxine
  10. Check your thyroid results

How the thyroid hormone system works

The thyroid is a butterfly-shaped gland in the neck that produces two main hormones: thyroxine, known as T4, and triiodothyronine, known as T3. These hormones regulate metabolism, heart rate, body temperature, energy levels, and a wide range of other bodily processes.

The pituitary gland, situated at the base of the brain, monitors circulating thyroid hormone levels and adjusts TSH output to keep them in range. TSH stands for thyroid stimulating hormone. When thyroid hormone levels fall, TSH rises to push the thyroid to produce more. When thyroid hormone levels rise, TSH falls to tell the thyroid to slow down.

This feedback loop means TSH moves in the opposite direction to thyroid hormones. A high TSH signals an underactive thyroid. A low TSH signals an overactive one.


What is a normal TSH level in the UK

Reference ranges vary slightly between UK laboratories, but the broadly accepted normal range is:

TSH levelCategory
Below 0.4 mU/LLow, indicates possible hyperthyroidism
0.4 to 4.5 mU/LNormal range
Above 4.5 mU/LHigh, indicates possible hypothyroidism

Some laboratories quote a slightly narrower normal range. Pregnant women have different reference ranges, particularly in the first trimester, where a TSH up to 2.5 mU/L is the upper target and lower TSH values are more common due to the stimulating effect of hCG on the thyroid.

A TSH below 0.1 mU/L is generally described as suppressed rather than merely low, and carries a different clinical significance from a borderline result of 0.3 mU/L.


What a low or suppressed TSH means

A low TSH means the pituitary is detecting too much thyroid hormone in the circulation. The degree of suppression matters.

A mildly low TSH in the range of 0.1 to 0.4 mU/L, with normal free T4 and free T3, describes subclinical hyperthyroidism. There is more circulating thyroid activity than optimal, but not enough to push the thyroid hormone levels themselves outside their reference ranges.

A suppressed TSH below 0.1 mU/L alongside a raised free T4 or raised free T3, or both, confirms overt hyperthyroidism. The thyroid is producing enough excess hormone to push the measured values above normal.

Overt hyperthyroidism affects approximately 0.5% of the UK population at any one time, and is around five to ten times more common in women than in men.


Symptoms of an overactive thyroid

The symptoms of hyperthyroidism reflect a body running in a state of metabolic overdrive. They can develop gradually and are sometimes attributed to anxiety or lifestyle before the thyroid connection is made.

The most common symptoms are:

  • Unintentional weight loss despite a normal or increased appetite
  • Rapid or irregular heartbeat, including palpitations
  • Anxiety, nervousness, or irritability
  • Heat intolerance and excessive sweating
  • Tremor, particularly of the hands
  • Fatigue and muscle weakness
  • Frequent or loose bowel movements
  • Difficulty sleeping
  • Thinning hair or hair loss
  • In women, irregular or lighter periods

Graves' disease, the most common cause of hyperthyroidism, can also cause Graves' ophthalmopathy: a condition where the eyes appear to protrude, feel gritty or dry, or are sensitive to light. This occurs because the same immune process that affects the thyroid also affects the tissues behind the eyes.

Older adults with hyperthyroidism often present differently from younger patients. The classic anxious, trembling presentation is less common. Instead, they may present with atrial fibrillation, unexplained weight loss, or unexplained heart failure without prominent thyroid symptoms.


What causes a low TSH

Graves' disease

Graves' disease is an autoimmune condition and the most common cause of hyperthyroidism in the UK, accounting for around 70 to 80% of cases. The immune system produces antibodies called thyroid-stimulating immunoglobulins that bind to TSH receptors on the thyroid gland and stimulate it continuously, independently of TSH. The result is persistent overproduction of thyroid hormones.

Graves' disease is more common in women and typically presents in early adulthood to middle age. A blood test for TSH receptor antibodies, known as TRAb, confirms the diagnosis.

Toxic nodular goitre and toxic adenoma

Nodules within the thyroid gland can develop autonomous function, producing thyroid hormones independently of TSH control. A single overactive nodule is called a toxic adenoma. Multiple overactive nodules form a toxic multinodular goitre. These conditions become more common with age and are more prevalent in areas of the world with low iodine intake.

Thyroiditis

Inflammation of the thyroid, known as thyroiditis, can cause a transient release of stored thyroid hormones into the bloodstream, producing a temporary hyperthyroid phase. This occurs in postpartum thyroiditis, which affects around 5 to 10% of women in the year following delivery, and in subacute thyroiditis, which typically follows a viral illness.

The hyperthyroid phase of thyroiditis is usually self-limiting and does not require antithyroid treatment. It is often followed by a temporary hypothyroid phase before the thyroid returns to normal function, though a proportion of women with postpartum thyroiditis develop permanent hypothyroidism.

Excessive iodine intake

The thyroid uses iodine to produce its hormones. Very high iodine intake, from certain medications or supplements, can trigger hyperthyroidism in susceptible individuals. Amiodarone, a cardiac medication, contains large amounts of iodine and can cause both hyper- and hypothyroidism. Iodine-containing contrast media used in CT scans can also trigger thyroid dysfunction in people with pre-existing thyroid nodules.


Subclinical hyperthyroidism: low TSH with normal T4 and T3

Subclinical hyperthyroidism is defined as a persistently low TSH with free T4 and free T3 both within normal range. The patient may or may not have symptoms.

Whether to treat subclinical hyperthyroidism depends on the degree of suppression and the presence of risk factors. The main considerations are:

Atrial fibrillation. A persistently suppressed TSH increases the risk of atrial fibrillation by approximately three-fold. This risk is highest in older adults.

Bone density. Thyroid hormones affect bone turnover. A chronically suppressed TSH in post-menopausal women is associated with reduced bone mineral density and increased fracture risk.

Symptom burden. Some patients with subclinical hyperthyroidism are significantly symptomatic. For others, the TSH is incidentally low and they report no symptoms at all.

Current NICE guidance recommends repeating thyroid function tests in three months before making any treatment decisions, unless there is evidence of atrial fibrillation or significant bone loss. Many cases of mild subclinical hyperthyroidism resolve spontaneously.


How an overactive thyroid is diagnosed

A low or suppressed TSH on a routine blood test is the usual starting point. The next step is to check free T4 and free T3 to confirm whether overt hyperthyroidism is present.

Further investigation typically includes:

Thyroid antibodies. TSH receptor antibodies confirm Graves' disease. Thyroid peroxidase antibodies, known as TPO antibodies, are associated with autoimmune thyroid conditions generally.

Thyroid ultrasound. Ultrasound identifies nodules, assesses gland size, and helps characterise the type of thyroid disease present.

Technetium or iodine uptake scan. A thyroid isotope scan shows which parts of the gland are overactive. This is used to distinguish Graves' disease from toxic nodular disease and is important when considering radioiodine treatment.


Treatment options for hyperthyroidism in the UK

There are three main treatment approaches, and the choice between them depends on the cause, the severity, the patient's age, and personal preference.

Antithyroid medications

Carbimazole is the first-line antithyroid drug in the UK. It works by blocking thyroid hormone synthesis. It is used to bring thyroid function back to normal before a decision is made about longer-term treatment, and in some patients it is used as a long-term management strategy.

The main risk with carbimazole is agranulocytosis, a dangerous drop in white blood cells, which affects approximately 0.3% of patients. Patients are advised to report sore throats, mouth ulcers, or fever urgently and to stop the medication pending a blood count. Carbimazole is also contraindicated in early pregnancy, where propylthiouracil is preferred.

Radioiodine treatment

Radioiodine is taken as a capsule or drink and concentrates in the thyroid, delivering radiation that destroys overactive thyroid tissue. It is the definitive treatment of choice for many UK adults with Graves' disease or toxic nodular disease and is effective in a single treatment in around 70 to 80% of cases.

The main consequence of radioiodine is that it frequently results in hypothyroidism over the following months to years. Most patients who have radioiodine will eventually require levothyroxine replacement. This is planned for and managed with regular thyroid function monitoring.

Thyroid surgery

Surgical removal of part or all of the thyroid gland is effective and appropriate in specific circumstances: a very large goitre causing compressive symptoms, suspected malignancy, or patient preference. Total thyroidectomy results in permanent hypothyroidism requiring lifelong levothyroxine.


A low TSH on levothyroxine

People taking levothyroxine for hypothyroidism sometimes have a low or suppressed TSH on a routine check. This almost always reflects over-treatment, meaning the levothyroxine dose is too high.

A consistently suppressed TSH on levothyroxine carries the same long-term risks as untreated subclinical hyperthyroidism: atrial fibrillation and bone density loss. Dose adjustment is usually straightforward, with a repeat TSH check four to six weeks after any change.

A small number of patients require a deliberately suppressed TSH. This applies to people who have been treated for differentiated thyroid cancer, where a low TSH reduces the stimulus for any residual thyroid tissue to grow. Outside this setting, a suppressed TSH on levothyroxine generally warrants dose reduction.


Check your thyroid results

If you have your thyroid function test results and want to understand what each value means, the free blood test explainer covers the full TFTs panel. Enter your TSH, free T4, and free T3 to see where each value sits against the reference range and get a plain-English explanation of what the pattern indicates.

The thyroid panel is one of eight covered in the tool, alongside FBC, liver function, U&Es, HbA1c, lipid profile, iron studies, and bone profile.

Explore the free blood test explainer


This article is for general information only. It is not a substitute for clinical assessment. If you have received a low TSH result, speak to your GP or an endocrinologist for advice on investigation and management.

Next Step

Want this implemented in your clinic?

Free 30-minute strategy call. No pitch — just practical next steps.

Book a free call

More articles